Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
2U Inc is an education & training services business based in the US. 2U shares (TWOU) are listed on the NASDAQ and all prices are listed in US Dollars. 2U employs 3,982 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $10.92 |
|---|---|
| 52-week range | $7.28 - $46.52 |
| 50-day moving average | $9.88 |
| 200-day moving average | $18.40 |
| Wall St. target price | $17.73 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.66 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $10.92 from 2022-06-29
| 1 week (2022-06-23) | 11.31% |
|---|---|
| 1 month (2022-05-27) | 8.23% |
| 3 months (2022-03-30) | -16.51% |
| 6 months (2021-12-30) | -46.73% |
| 1 year (2021-06-30) | -73.79% |
|---|---|
| 2 years (2020-06-30) | -71.23% |
| 3 years (2019-06-28) | 37.64 |
| 5 years (2017-06-30) | 46.92 |
Valuing 2U stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of 2U's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
2U's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 18.2533. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into 2U's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $966.5 million |
|---|---|
| Gross profit TTM | $676.3 million |
| Return on assets TTM | -5.43% |
| Return on equity TTM | -35.17% |
| Profit margin | -28.45% |
| Book value | $8.53 |
| Market capitalisation | $786.9 million |
TTM: trailing 12 months
We're not expecting 2U to pay a dividend over the next 12 months.
Over the last 12 months, 2U's shares have ranged in value from as little as $7.28 up to $46.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 2U's is 1.2105. This would suggest that 2U's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
2U, Inc. operates as an education technology company in the United States and internationally. The company operates through two segments, Degree Program and Alternative Credential. The Degree Program segment provides the technology and services to nonprofit colleges and universities to enable the online delivery of degree programs. This segment targets students seeking an undergraduate or graduate degree. The Alternative Credential segment offers online open courses, executive education programs, technical cources, skills-based boot camps, and micro-credential programs through nonprofit colleges and universities. This segment targets students seeking to reskill or upskill through shorter duration and lower-priced offerings.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
